Sort
30,917 grants matching “tumor microenvironment”
The role of Myeloid cells in pediatric-high grade gliomas
$594,958Dolores Hambardzumyan · University Of Pennsylvania · R01 · FY2025 · CA
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$594,912Russell William Jenkins · Massachusetts General Hospital · R37 · FY2024 · CA
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
$594,901Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$594,784Amir Zarrinpar · University Of California, San Diego · U01 · FY2024 · CA
Genetically-engineered Bacteria Overcome Therapy Resistance
$594,699Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Combinatorial Immunotherapy using a Multivalent Drug Conjugate for GBM Treatment
$594,675Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2023 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$594,636Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2019 · NS
Instructive roles of mesenchymal proteoglycans in hair follicle morphogenesis and maintenance
$594,600Jiang Chen · State University New York Stony Brook · R01 · FY2024 · AR
Project 2 - Epigenetic Drivers of Lineage Plasticity in Lung Cancer
$594,494Matthew Gilbert Oser · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Reprogram long-lived effector T cells for cancer immunotherapy
$594,393Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Reprogram long-lived effector T cells for cancer immunotherapy
$594,393Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Stress, the Immune System and Basal Cell Carcinoma
$594,388Ronald Glaser · Ohio State University · R01 · FY2007 · CA
Transcriptional Reprogramming in Melanoma Plasticity
$594,386Chengyu Liang · Wistar Institute · R01 · FY2025 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$594,336Zihai Li · Ohio State University · R01 · FY2022 · CA
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
$594,235Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Angiogenesis-targeting therapy for glioblastoma
$594,234Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2013 · CA
A novel AR degrader in castrate-resistant prostate cancer
$594,227Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2023 · CA
Dissecting Phenotype Switching in Early Stage Melanomas
$594,183Markus Schober · New York University School Of Medicine · R01 · FY2024 · CA
Contemporary Approaches to Cancer Cell Signaling and Communication
$594,157Jing Yang · University Of California, San Diego · T32 · FY2021 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$594,047John Tanner Wilson · Vanderbilt University · R01 · FY2023 · EB
Developing novel bispecific antibodies for cancer treatment
$594,007Zhen Fan · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Vevo LAZR Photoacoustic Imaging System
$593,680David J Hall · University Of California, San Diego · S10 · FY2016 · OD
Osteoporosis in HIV-infected Postmenopausal Women
$593,634Elizabeth J. Shane · Columbia University Health Sciences · R01 · FY2009 · AI
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
$593,572Xiangwei Wu · University Of Tx Md Anderson Can Ctr · N01 · FY2023 · CA
Studying macrophage polarization in search for predictive and prognostic markers of breast cancer
$593,531Jan Matt Van De Rijn · Stanford University · R01 · FY2025 · CA